The consequences of a public health insurance option: Evidence from Medicare Part D prescription drug markets
This paper examines a public option competing alongside private insurers in Medicare Part D. We estimate a random coefficient demand system and oligopoly supply-side model with endogenous premium subsidies and risk adjustment payments. If the public option does not affect health risk sorting, counte...
Saved in:
Main Authors: | MILLER, Daniel P., YEO, Jungwon |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2013
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soe_research/1270 https://ink.library.smu.edu.sg/context/soe_research/article/2269/viewcontent/ConsequencesPublicHealth_Insurance_2013_wp.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
The consequences of a public health insurance option: Evidence from Medicare Part D
by: MILLER, Daniel P., et al.
Published: (2019) -
Estimating Dynamic Discrete Choice Models of Product Differentiation: An Application to Medicare Part D with Switching Costs
by: MILLER, Daniel P., et al.
Published: (2012) -
The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
by: Han, Dan
Published: (2023) -
Strategic options for brand-name prescription drugs when patents expire.
by: Mehta, S.C., et al.
Published: (2013) -
Motor insurance in Singapore : problems and prescriptions
by: Ang, Cheng Sim, et al.
Published: (2015)